Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-18-014486)

Filing Details

Accession Number:: 0001144204-18-014486
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-13 22:00:09
Reporting Period:: 2016-07-13

Accepted Time:: 2018-03-13 22:00:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1551986	Innovate Biopharmaceuticals Inc.	INNT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1251818	H David Clarke	2655 First Street, Suite 250 Simi Valley CA 93065	Former Ceo And Director	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-07-13	15,000	$4.50	445,043	No	4	P	Direct
Common Stock	Acquisiton	2017-01-24	175,000	$0.00	620,043	No	4	A	Direct
Common Stock	Acquisiton	2017-03-16	70,000	$1.50	690,043	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2017-06-23	172,414	$0.58	862,457	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2017-06-30	33,621	$0.00	896,078	No	4	A	Indirect	See footnote
Common Stock	Acquisiton	2017-06-30	13,467	$0.00	909,545	No	4	A	Indirect	See footnote
Common Stock	Acquisiton	2017-11-09	100,000	$0.00	1,009,545	No	4	A	Direct
Common Stock	Acquisiton	2017-11-29	366,159	$0.45	1,375,704	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2018-01-24	17,746	$0.00	1,393,450	No	4	A	Indirect	See footnote
Common Stock	Acquisiton	2018-01-25	25,000	$0.00	1,418,450	No	4	A	Direct
Common Stock	Acquisiton	2018-01-26	300,000	$0.35	1,718,450	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	A	Direct
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	A	Indirect	See footnote
No	4	A	Indirect	See footnote
No	4	A	Direct
No	4	P	Indirect	See footnote
No	4	A	Indirect	See footnote
No	4	A	Direct
No	4	P	Indirect	See footnote

Footnotes

Shares of restricted common stock granted under Issuer's 2012 Omnibus Incentive Plan.
Reporting Person's beneficial ownership includes: 71,402 shares of common stock held by his spouse and 1,063,350 shares of common stock held by GSB Holdings, Inc., a corporation owned by his spouse and children.